BriaCell Therapeutics Announces Proceeds of US$12.88 Million from Warrant Exercises

NEXT STORY
CorMedix Inc. Completes Sale of $1.3 Million of NOL Tax Benefits Through The New Jersey Economic Development Authority Program
PREV STORY
Quipt Home Medical to Participate at the Sidoti Virtual Investor Conference on June 23rd – 24th
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Roche launches Elecsys Epstein-Barr Virus (EBV) immunoassay panel to improve EBV infection staging

author_avatar
NASDAQ Market News

Delcath Systems Closes $9.5 Million Private Placement

author_avatar
NASDAQ Market News

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

author_avatar
NASDAQ Market News